Results 141 to 150 of about 3,978,530 (165)
Some of the next articles are maybe not open access.
Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders
Journal of Psychoactive Drugs, 2017Recent research suggests that functional connectivity changes may be involved in the pathophysiology of psychiatric disorders. Hyperconnectivity in the default mode network has been associated with psychopathology, but psychedelic serotonin agonists like psilocybin may profoundly disrupt these dysfunctional neural network circuits and provide a novel ...
Kelan Thomas +2 more
openaire +2 more sources
Innovations in group‐based psilocybin‐assisted therapy of major depression in patients with cancer
Cancer, 2023Several recent studies have investigated psilocybin as a novel therapeutic compound for the treatment of existential distress in patients with cancer, demonstrating persistent, positive effects on mood. This editorial discusses two articles in the current issue of Cancer that report findings of a group‐based psilocybin‐assisted intervention for ...
Johannes Thrul +4 more
openaire +2 more sources
General Hospital Psychiatry
Psilocybin-assisted therapy (PAT) shows promise for cancer-related depression, yet little research has examined how therapeutic context shapes patient experiences. While set (mindset) and setting (environment) are considered central to psychedelic treatment, empirical evidence on their role in PAT acceptability remains limited.
Zachary Sager
exaly +3 more sources
Psilocybin-assisted therapy (PAT) shows promise for cancer-related depression, yet little research has examined how therapeutic context shapes patient experiences. While set (mindset) and setting (environment) are considered central to psychedelic treatment, empirical evidence on their role in PAT acceptability remains limited.
Zachary Sager
exaly +3 more sources
Psilocybin‐assisted therapy reduces heavy drinking in patients with AUD
The Brown University Psychopharmacology Update, 2022Two sessions of psilocybin‐assisted psychotherapy resulted in reduced heavy‐drinking days and other alcohol‐related problems relative to placebo plus psychotherapy in a randomized trial involving patients with alcohol use disorder (AUD). There were no serious adverse events associated with psilocybin administration, and no signs of psychotic ...
openaire +1 more source
Social Acceptability of Psilocybin-Assisted Therapy for Existential Distress at the End of Life: A Population-Based Survey [PDF]
Michel Dorval +2 more
exaly +2 more sources
Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis
Journal of Affective DisordersThis systematic review and meta-analysis of six randomized controlled trials aimed to investigate the temporal changes in the efficacy and safety of psilocybin treatment for major depressive disorder (MDD).Separate meta-analyses were conducted for standard-dose psilocybin (25 mg/session, or 20-30 mg/70 kg/session) and low-dose psilocybin (10 mg/session
Taro, Kishi +4 more
openaire +2 more sources
Psilocybin-assisted therapy for depression: How do we advance the field?
Australian & New Zealand Journal of Psychiatry, 2019In the quest for new treatment options for depression, attention is being paid to the potential role of psychedelic drugs. Psilocybin is of particular interest given its mechanism of action, its benefits in early trials and its relatively low side effects burden.
Sally E Meikle +8 more
openaire +3 more sources
BMJ Supportive & Palliative Care
Objectives To assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy (PAT) for demoralisation in terminally ill patients receiving home hospice care. Methods In this open-label pilot trial, 4607 home ...
Yvan Beaussant +16 more
openaire +2 more sources
Objectives To assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy (PAT) for demoralisation in terminally ill patients receiving home hospice care. Methods In this open-label pilot trial, 4607 home ...
Yvan Beaussant +16 more
openaire +2 more sources
Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-Report
Journal of Palliative MedicineIntroduction: Psilocybin-assisted therapy (PAT) has gained traction in palliative care as a treatment for existential distress in the last decade. Patients with brain cancer have been excluded from studies, yet they stand to benefit as much as other patients with cancer-related psychological distress.
Jean-François Stephan, Sani Karam
openaire +2 more sources
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?
Journal of Psychoactive Drugs, 2023Brianna Altman +2 more
exaly

